Pleural Mesotheliomas Completed Phase 2 Trials for Cixutumumab (DB12250)

Also known as: Pleural Mesothelioma

IndicationStatusPhase
DBCOND0029910 (Pleural Mesotheliomas)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01160458Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With ChemotherapyTreatment